Company Comparison
Juno Therapeutics vs 54gene
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Juno Therapeutics | 54gene |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | — | Lagos, Nigeria |
| Founded | 2013 | 2019 |
| Status | Active | Active |
| Last Funding Stage | — | Series B |
| Total Funding | $300M | $45M |
| Valuation | — | — |
What They Build
Juno Therapeutics
Juno Therapeutics, Inc. was an American biopharmaceutical company founded in 2013 through a collaboration of the Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and pediatrics partner Seattle Children's Research Institute.
54gene
African genomics research company advancing precision medicine through genetic research focused on African populations.
Key Investors
Juno Therapeutics
Sector Overlap
Both Juno Therapeutics and 54gene operate in Biotech.
Browse all Biotech companies →Websites
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.
Now in alpha with select funds. 14-day trial available.